DT MedTech, LLC is dedicated to providing innovative surgical solutions for lower extremity surgeons with state-of-the art devices designed to ensure better patient outcomes.
DT MedTech was originally formed to exploit the intellectual property of European Foot Platform S. A. R. L. (EFP) and Prof. Beat Hintermann to improve patient care with the highest quality products. Prof. Beat Hintermann, Chairman of the Clinic for Orthopaedics and Traumatology at Kantonsspital Baselland in Liestal, Switzerland, developed the Hintermann Series H3® mobile bearing Total Ankle Replacement system more than 20 years ago which has realized continued clinical use and success in the global marketplace. In June 2019, the Hintermann Series H3 system received FDA PMA approval for the use of the product in the United States to replace the ankle joint in primary surgeries.
In November 2017, DT MedTech and Prof. Hintermann introduced the Hintermann Series H2® Total Ankle Replacement system. This innovative new implant is a semi-constrained Total Ankle Replacement system that is indicated for use as non-cemented implant outside of the United States and as a cemented implant within the United States. The Hintermann Series H2is indicated globally for use as a primary ankle replacement or in revision surgery.
The Hintermann Series Total Ankle Replacement Systems, allows surgeons, globally, to have the opportunity, using a single instrument set, to offer a full solution to their patients using the H2 and H3 to perform primary and revision total ankle replacements.